GSK Plc (GSK)
51.91
+0.13
(+0.25%)
USD |
NYSE |
Aug 25, 12:36
GSK Price to Book Value : 4.483 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.472 |
| August 21, 2026 | 4.527 |
| August 20, 2026 | 4.488 |
| August 19, 2026 | 4.567 |
| August 18, 2026 | 4.418 |
| August 17, 2026 | 4.343 |
| August 14, 2026 | 4.277 |
| August 13, 2026 | 4.357 |
| August 12, 2026 | 4.344 |
| August 11, 2026 | 4.396 |
| August 10, 2026 | 4.505 |
| August 07, 2026 | 4.574 |
| August 06, 2026 | 4.506 |
| August 05, 2026 | 4.444 |
| August 04, 2026 | 4.451 |
| August 03, 2026 | 4.449 |
| July 31, 2026 | 4.464 |
| July 30, 2026 | 4.497 |
| July 29, 2026 | 4.596 |
| July 28, 2026 | 4.639 |
| July 27, 2026 | 4.489 |
| July 24, 2026 | 4.435 |
| July 23, 2026 | 4.382 |
| July 22, 2026 | 4.384 |
| July 21, 2026 | 4.386 |
| Date | Value |
|---|---|
| July 20, 2026 | 4.322 |
| July 17, 2026 | 4.470 |
| July 16, 2026 | 4.558 |
| July 15, 2026 | 4.444 |
| July 14, 2026 | 4.426 |
| July 13, 2026 | 4.516 |
| July 10, 2026 | 4.558 |
| July 09, 2026 | 4.532 |
| July 08, 2026 | 4.536 |
| July 07, 2026 | 4.605 |
| July 06, 2026 | 4.585 |
| July 02, 2026 | 4.634 |
| July 01, 2026 | 4.431 |
| June 30, 2026 | 4.528 |
| June 29, 2026 | 4.509 |
| June 26, 2026 | 4.482 |
| June 25, 2026 | 4.430 |
| June 24, 2026 | 4.362 |
| June 23, 2026 | 4.446 |
| June 22, 2026 | 4.332 |
| June 18, 2026 | 4.326 |
| June 17, 2026 | 4.453 |
| June 16, 2026 | 4.459 |
| June 15, 2026 | 4.460 |
| June 12, 2026 | 4.529 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 11.09 |
| Eli Lilly & Co. | 34.82 |
| Merck & Co., Inc. | 9.097 |
| Pfizer Inc. | 1.904 |
| Sanofi | 1.542 |
Price to Book Value Related Metrics
| PE Ratio | 16.35 |
| PS Ratio | 2.377 |
| PEG Ratio | 0.3411 |
| Price to Free Cash Flow | 16.00 |
| Price | 51.91 |
| Earnings Yield | 6.11% |
| Market Cap | 105.00B |
| PEGY Ratio | 0.3177 |
| Operating PE Ratio | 9.509 |
| Normalized PE Ratio | 11.26 |